Atlas Trials

Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis

Clinical trial NCT05623592 · UNKNOWN

Trial details

NCT number
NCT05623592
Sponsor
University of Bonn
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Giant Cell Arteritis
Start date
2022-11-23
Primary completion
2025-11-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.